Planta Med 2007; 73(7): 644-649
DOI: 10.1055/s-2007-981534
Pharmacology
Original Paper
© Georg Thieme Verlag KG Stuttgart · New York

Antianaphylactic Properties of 7-Epiclusianone, a Tetraprenylated Benzophenone Isolated from Garcinia brasiliensis

Josiane Sabbadini Neves1 , Luciana Pontes Coelho1 , Renato Sérgio Balão Cordeiro1 , Marcia Paranho Veloso2 , Patricia Machado Rodrigues e Silva1 , Marcelo Henrique dos Santos2 , Marco Aurélio Martins1
  • 1Laboratory of Inflammation, Department of Physiology and Pharmacodynamics, Oswaldo Cruz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, RJ, Brazil.
  • 2Laboratory of Phytochemistry and Medicinal Chemistry, Department of Pharmacy, Alfenas Federal University (UNIFAL-MG), Alfenas, Minas Gerais, MG, Brazil.
Further Information

Publication History

Received: February 14, 2007 Revised: April 26, 2007

Accepted: April 27, 2007

Publication Date:
11 June 2007 (online)

Preview

Abstract

Prior studies have emphasized the anti-inflammatory and antioxidant properties of polyisoprenylated benzophenone derivatives, but their putative effect on allergic conditions has not yet been addressed. In the current study, the naturally occurring 7-epiclusianone, isolated from Garcinia brasiliensis, was investigated to check its effectiveness on allergen-evoked intestinal spasm. The standard antiallergic azelastine was used for comparison. We found that 7-epiclusianone and azelastine inhibited antigen-induced contractions of guinea pig ileum with similar IC50 values (2.3 ± 1.1 μM and 3.3 ± 1.2 μM, respectively). A similar blockade of anaphylactic histamine release from the ileum was also noted. In contrast, azelastine was more potent than 7-epiclusianone to prevent spasms induced by histamine (IC50 = 6.3 ± 0.2 nM and 3.7 ± 0.1 μM, respectively). These findings reveal that 7-epiclusianone is clearly active against the anaphylactic response and should be considered as a molecular template in drug discovery for allergic syndromes.

Prof. Dr. Marco Aurélio Martins

Laboratory of Inflammation

Oswaldo Cruz Institute

Oswaldo Cruz Foundation (FIOCRUZ)

Av. Brasil 4365

Manguinhos CEP

21045-900 Rio de Janeiro

RJ

Brazil

Phone: +55-21-2573-0844

Fax: +55-21-2558-7382

Email: mmartins@ioc.fiocruz.br